sb 216763 has been researched along with Colitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dunger, N; Falk, W; Hofmann, C; Obermeier, F; Schölmerich, J | 1 |
1 other study(ies) available for sb 216763 and Colitis
Article | Year |
---|---|
Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation.
Topics: Adjuvants, Immunologic; Adult; Aged; Animals; CD3 Complex; Cells, Cultured; Chronic Disease; Colitis; Cyclic AMP Response Element-Binding Protein; Cytokines; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Intestines; Lipopolysaccharides; Lithium Chloride; Lymph Nodes; Male; Maleimides; Mice; Mice, Inbred BALB C; Middle Aged; Mucous Membrane; NF-kappa B; Oligodeoxyribonucleotides; Toll-Like Receptors | 2010 |